Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.86 USD | +8.73% | +10.29% | +47.89% |
Apr. 11 | Summit Therapeutics Inc. Appoints Dr. Mostafa Ronaghi to Its Board of Directors | CI |
Apr. 09 | Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed | RE |
Business Summary
Number of employees: 105
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Director of Finance/CFO | 46 | 19-11-30 | |
Howard West
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-18 |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-15 |
Will Black
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dave Gancarz
PRN | Corporate Officer/Principal | - | - |
Campbell Hair
HRO | Human Resources Officer | - | 20-09-30 |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 21-11-02 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Robert Booth
BRD | Director/Board Member | 70 | 22-09-27 |
Director of Finance/CFO | 46 | 19-11-30 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Kenneth Clark
BRD | Director/Board Member | 65 | 21-10-06 |
Director/Board Member | 63 | 22-11-14 | |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 21-11-02 |
Michelle Xia
BRD | Director/Board Member | 58 | 23-01-15 |
Ujwala Mahatme
BRD | Director/Board Member | 59 | 20-07-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 701,697,179 | 83,130,080 ( 11.85 %) | 0 | 11.85 % |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+47.89% | 2.49B | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- SMMT Stock
- Company Summit Therapeutics Inc.